AlphaQ Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,178
Closed -$503K 108
2024
Q1
$503K Sell
3,178
-803
-20% -$128K 0.3% 76
2023
Q4
$624K Sell
3,981
-197
-5% -$30.2K 0.43% 53
2023
Q3
$651K Sell
4,178
-517
-11% -$85.3K 0.56% 48
2023
Q2
$777K Buy
4,695
+316
+7% +$51K 0.57% 51
2023
Q1
$679K Sell
4,379
-641
-13% -$104K 0.58% 47
2022
Q4
$887K Buy
+5,020
New +$867K 0.77% 37

Other funds holding JNJ

AlphaQ Advisors's JNJ Position: Q2 2024 in Review

AlphaQ Advisors sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 3,178 shares — an estimated $503K sold.

AlphaQ Advisors first reported a position in JNJ in Q4 2022 and held it in 6 quarters. The position peaked at $887K in Q4 2022. 3,802 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • AlphaQ Advisors reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • AlphaQ Advisors sold 3,178 Johnson & Johnson shares in Q2 2024, an estimated $503K.
  • AlphaQ Advisors first reported a position in Johnson & Johnson in Q4 2022 and held it in 6 quarters.
  • AlphaQ Advisors's Johnson & Johnson position peaked at $887K in Q4 2022.
  • 3,802 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on AlphaQ Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.